Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper

The effect of gliclazide and glibenclamide on preconditioning of the human myocardiumLOUBANI, Mahmoud; FOWLER, Alan; STANDEN, Nicholas B et al.European journal of pharmacology. 2005, Vol 515, Num 1-3, pp 142-149, issn 0014-2999, 8 p.Article

Study of the solubilization of gliclazide by aqueous micellar solutionsALKHAMIS, Khouloud A; ALLABOUN, Hussien; AL-MOMANI, Wafa'A Y et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 4, pp 839-846, issn 0022-3549, 8 p.Article

Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulationsBERECKA, Anna; GUMIENICZEK, Anna; HOPKALA, Hanna et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 319-325, issn 1060-3271, 7 p.Article

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetesCHARBONNEL, B; SCHERNTHANER, G; BRUNETTI, P et al.Diabetologia (Berlin). 2005, Vol 48, Num 6, pp 1093-1104, issn 0012-186X, 12 p.Article

Determination of aminoheterocycle and azabicycle in gliclazide bulk by capillary zone electrophoresis with amperometric detectionJIN LV; QINGJIANG WANG; XIANG CHEN et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 3-4, pp 843-847, issn 0731-7085, 5 p.Article

High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasmaKUO, Chien-Yuan; WU, Shou-Mei.Journal of chromatography. 2005, Vol 1088, Num 1-2, pp 131-135, issn 0021-9673, 5 p.Conference Paper

Free radical scavenging activity of sulfonylureas: A clinical assessment of the effect of gliclazideJENNINGS, P. E; BELCH, J. J. F.Metabolism, clinical and experimental. 2000, Vol 49, Num 2, pp 23-26, issn 0026-0495, SUP1Conference Paper

In Vitro and In Vivo Evaluation of a Novel Push-Pull Osmotic Pump with Orifices on Both Side SurfacesWEI LI; GANI DU; XINGGANG YANG et al.Drug development and industrial pharmacy. 2008, Vol 34, Num 12, pp 1350-1355, issn 0363-9045, 6 p.Article

Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical settingGÖKALP, Osman; GUNES, Arzu; CAM, Hakan et al.European journal of clinical pharmacology. 2011, Vol 67, Num 12, pp 1223-1229, issn 0031-6970, 7 p.Article

Effect of gliclazide immobilization into layered double hydroxide on drug releaseAMBROGI, V; PERIOLI, L; CIARNELLI, V et al.European journal of pharmaceutics and biopharmaceutics. 2009, Vol 73, Num 2, pp 285-291, issn 0939-6411, 7 p.Article

Gliclazide at a lower concentration than therapeutic dose increases the sensitivity of insulin secretion to glucose in perfused rat pancreasMOKUDA, O; TANAKA, H; HAYASHI, T et al.Diabetes & metabolism. 2004, Vol 30, Num 2, pp 193-196, issn 1262-3636, 4 p.Article

Le médicament du mois : Gliclazide à libération modifiée (Uni Diamicron®) = Gliclazide modified release (Uni Diamicron®)SCHEEN, A. J.RMLG. Revue médicale de Liège. 2003, Vol 58, Num 10, pp 641-645, issn 0370-629X, 5 p.Article

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatmentSWEN, Jesse J; GUCHELAAR, Henk-Jan; BAAK-PABLO, Renee F et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 8, pp 461-468, issn 1744-6872, 8 p.Article

Gliclazide^{(Ddiamicron° 30 mg)} : Nouvelle forme : L'évaluation n'en sort pas renforcée = Glizalide (Diamicron® 30 mg) : new formulationLa Revue Prescrire. 2002, Vol 22, Num 224, issn 0247-7750, p. 11Article

Preparation and in vitro/in vivo evaluation of gliclazide loaded eudragit nanoparticles as a sustained release carriersDEVARAJAN, Padma V; SONAVANE, Ganeshchandra S.Drug development and industrial pharmacy. 2007, Vol 33, Num 2, pp 101-111, issn 0363-9045, 11 p.Article

Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with type 2 diabetesPERRIELLO, G; PAMPANELLI, S; DI PIETRO, C et al.Diabetic medicine. 2006, Vol 23, Num 3, pp 246-252, issn 0742-3071, 7 p.Article

Mécanismes moléculaires de l'insulinosécrétion = Molecular mechanisms of insulin secretionBATAILLE, D.Diabetes & metabolism. 2002, Vol 28, pp 4S7-4S13, issn 1262-3636, SUPConference Paper

Effect of gliclazide on islet transplantsJUANG, J.-H; KUO, C.-H; HSU, B. R.-S et al.Transplantation proceedings. 2002, Vol 34, Num 7, pp 2696-2697, issn 0041-1345, 2 p.Conference Paper

Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite DesignVIJAYALAKSHMI, P; KUSUM, V; NARENDRA, Devi C et al.Drug development and industrial pharmacy. 2008, Vol 34, Num 1, pp 33-45, issn 0363-9045, 13 p.Article

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic ratsAL-SALAMI, Hani; BUTT, Grant; TUCKER, Ian et al.European journal of drug metabolism and pharmacokinetics. 2012, Vol 37, Num 2, pp 99-108, issn 0378-7966, 10 p.Article

Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes : comparisons with gliclazide-based regimensCHARBONNEL, B; RODEN, M; URQUHART, R et al.Diabetologia (Berlin). 2005, Vol 48, Num 3, pp 553-560, issn 0012-186X, 8 p.Article

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetesBETTERIDGE, D. J; VERGES, B.Diabetologia (Berlin). 2005, Vol 48, Num 12, pp 2477-2481, issn 0012-186X, 5 p.Article

THE PHARMACOLOGY OF S1702, A NEW HIGHLY EFFECTIVE ORAL ANTIDIABETIC DRUG WITH UNUSUAL PROPERTIES. PROTECTIVE ACTIVITY OF S1702 ON THE MICROVASCULAR SYSTEM IN NORMAL AND DIABETIC RATS = PHARMACOLOGIE DU S1702, UN NOUVEL ANTIDIABETIQUE PER OS D'UNE GRANDE EFFICACITE AVEC DES PROPRIETES INHABITUELLES. EFFET PROTECTEUR DU S1702 SUR LE SYSTEME MICROVASCULAIRE CHEZ LES RATS NORMAUX ET DIABETIQUESDUHAULT J; LEBON F.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 10; PP. 1686-1690; ABS. FR. ALLEM.; BIBL. 23REF.Serial Issue

SURVEILLANCE EN MILIEU HOSPITALIER DE LA MISE EN ROUTE D'UN NOUVEAU TRAITEMENT ANTIDIABETIQUE: LE GLICLAZIDE (OU 1702 SE)DENARD Y; DARNAUD J.1972; REV. MED. TOULOUSE, ENSEIGN. DOCUM. INFORM.; FR.; DA. 1972; VOL. 8; NO 9; PP. 1739-1751 (7P.)Serial Issue